Valuation: Sanofi

Capitalization 95.89B 113B 88.36B 83.47B 155B 10,489B 159B 1,036B 407B 5,044B 423B 414B 17,973B P/E ratio 2026 *
11.6x
P/E ratio 2027 * 10.7x
Enterprise value 107B 125B 98.2B 92.76B 173B 11,657B 176B 1,151B 453B 5,606B 470B 460B 19,974B EV / Sales 2026 *
2.28x
EV / Sales 2027 * 2.08x
Free-Float
87.31%
Yield 2026 *
5.36%
Yield 2027 * 5.7%
1 day-0.97%
1 week-3.84%
Current month-4.00%
1 month+3.78%
3 months-3.64%
6 months-4.72%
Current year-4.00%
1 week 78.83
Extreme 78.83
83.42
1 month 75.33
Extreme 75.33
83.77
Current year 74.85
Extreme 74.85
84.97
1 year 74.85
Extreme 74.85
98.36
3 years 74.85
Extreme 74.85
110.88
5 years 74.85
Extreme 74.85
110.88
10 years 62.5
Extreme 62.5
110.88
Manager TitleAgeSince
Chief Executive Officer 61 17/02/2026
Director of Finance/CFO 63 01/04/2024
Chief Operating Officer 41 01/10/2023
Director TitleAgeSince
Director/Board Member 72 01/05/2014
Director/Board Member 60 30/04/2019
Director/Board Member 56 28/04/2020
Name Varia. Jan 1. Weight AuM
+1.75%3.66% 158 M€
Change 5d. change 1-year change 3-years change Capi.($)
-0.97%-3.84%-11.39%-22.02% 114B
-1.06%-0.64%+26.92%+151.88% 841B
-0.21%-2.09%+56.83%+45.17% 574B
-0.71%-1.13%+17.95%+27.17% 368B
-0.35%-0.75%+29.45%+14.60% 320B
-1.59%-2.14%+49.76%+26.78% 318B
-1.05%-0.60%+51.74%+5.63% 300B
-0.94%-2.09%+40.11%+39.04% 295B
-0.34%+0.54%+22.32%+40.21% 189B
+0.03%-0.49%+34.16%+69.22% 173B
Average -0.41%-0.64%+31.79%+39.77% 349.15B
Weighted average by Cap. -0.27%-0.50%+35.31%+59.30%

Financials

2026 *2027 *
Net sales 46.65B 54.86B 42.98B 40.6B 75.63B 5,102B 77.25B 504B 198B 2,454B 206B 201B 8,743B 49.55B 58.27B 45.65B 43.13B 80.34B 5,420B 82.06B 535B 210B 2,606B 219B 214B 9,287B
Net income 8.73B 10.27B 8.05B 7.6B 14.16B 955B 14.46B 94.33B 37.08B 459B 38.53B 37.7B 1,637B 9.46B 11.13B 8.72B 8.24B 15.35B 1,035B 15.67B 102B 40.19B 498B 41.76B 40.87B 1,774B
Net Debt 10.68B 12.56B 9.84B 9.3B 17.32B 1,168B 17.69B 115B 45.36B 562B 47.12B 46.12B 2,002B 7.06B 8.3B 6.51B 6.15B 11.45B 772B 11.69B 76.28B 29.99B 371B 31.16B 30.49B 1,323B
Logo Sanofi
Sanofi is the largest European pharmaceutical group. Net sales by family of products break down as follows: - pharmaceutical products (81.8%): prescription drugs for the treatment of multiple sclerosis, neurological diseases, inflammatory diseases, autoimmune diseases, rare diseases, cancers and rare hematological diseases; - human vaccines (18.2%): pediatric vaccines, vaccines for flu, meningitis, and polio, booster vaccines, and vaccines for travelers and endemic areas. At the end of 2025, the group had 37 production sites worldwide. Net sales are distributed geographically as follows: France (3.9%), Europe (17.1%), the United States (50.8%), China (6%) and other (22.2%).
Employees
74,846
Date Price Change Volume
13/04/26 79.41 -0.97% 1,740,000
10/04/26 80.19 -0.90% 2,027,807
09/04/26 80.92 +0.06% 2,905,738
08/04/26 80.87 +0.45% 4,090,098
Trader
Investor
Global
Quality
ESG MSCI
AA
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
24
Last Close Price
79.41EUR
Average target price
96.18EUR
Spread / Average Target
+21.12%

Quarterly revenue - Rate of surprise